Ozari Health now offers compounded semaglutide starting at $86 per month and compounded tirzepatide starting at $125 per month through its nationwide telehealth platform. The company has also published updated GLP 1 pricing data for 2026, according to a recent announcement.

Key takeaways

  • Compounded semaglutide is available from $86 per month through Ozari Health’s telehealth service.
  • Compounded tirzepatide starts at $125 per month on the same platform.
  • The company released updated 2026 GLP 1 pricing data for consumers.
  • Ozari Health operates a nationwide telehealth platform for prescribing these medications.

What are compounded GLP 1 medications?

Compounded GLP 1 medications are customized versions of brand name drugs like semaglutide and tirzepatide. These are made by licensed compounding pharmacies when the original drugs are in short supply or when a patient needs a different dosage or formulation. Ozari Health’s compounded versions aim to provide lower cost alternatives to brand name products.

Semaglutide is the active ingredient in Ozempic and Wegovy, while tirzepatide is the active ingredient in Mounjaro and Zepbound. These medications are primarily used for type 2 diabetes and weight management.

How does Ozari Health’s telehealth platform work?

Ozari Health operates a nationwide telehealth platform that allows patients to consult with healthcare providers remotely. After an online consultation, eligible patients can receive prescriptions for compounded GLP 1 medications. The medications are then shipped directly to the patient’s home.

The company says the platform is designed to make these treatments more accessible and affordable. Patients do not need to visit a physical clinic for appointments.

Updated 2026 pricing data

Alongside the launch of its low cost compounded medications, Ozari Health has released updated GLP 1 pricing data for 2026. The company stated that this data is now live for consumers to review. The pricing information is intended to help patients compare costs and make informed decisions about their treatment options.

The original report did not provide specific details on what the 2026 pricing data includes or how it compares to other providers.

Cost comparison with brand name drugs

Brand name GLP 1 medications often cost several hundred to over a thousand dollars per month without insurance. Ozari Health’s compounded semaglutide at $86 per month and tirzepatide at $125 per month represent significant potential savings. However, compounded medications are not FDA approved and may have different risks compared to brand name drugs.

Patients should consult with their healthcare provider to determine if compounded medications are appropriate for their situation.

Frequently Asked Questions

Are compounded GLP 1 medications safe?

Compounded medications are not FDA approved like brand name drugs. They are made by licensed compounding pharmacies and must meet certain quality standards. Patients should discuss the risks and benefits with their healthcare provider before starting any compounded medication.

Who is eligible for Ozari Health’s compounded GLP 1 medications?

Eligibility is determined through an online consultation with a healthcare provider on Ozari Health’s telehealth platform. Patients with type 2 diabetes or those seeking weight management may be candidates, depending on their medical history and needs.

How do I get started with Ozari Health?

Patients can visit Ozari Health’s website to begin the process. They will complete an online consultation, and if approved, a prescription will be issued and the medication shipped to their home. The company operates nationwide.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.